477 related articles for article (PubMed ID: 33133102)
21. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
22. Serum uric acid as a sensitive concordant marker with lupus nephritis and new onset of renal damage: a prospective cohort study.
Elnady B; Almalki A; Abdel-Fattah MM; Desouky DE; Attar M
Clin Rheumatol; 2021 May; 40(5):1827-1834. PubMed ID: 33094396
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of serum C4d levels in patients with systemic lupus erythematosus and its relation to lupus nephritis.
Saadati N; Miri M
Caspian J Intern Med; 2023; 14(2):231-236. PubMed ID: 37223281
[TBL] [Abstract][Full Text] [Related]
24. Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients.
Liu XR; Qi YY; Zhao YF; Cui Y; Zhao ZZ
Ren Fail; 2023 Dec; 45(1):2174355. PubMed ID: 36946374
[TBL] [Abstract][Full Text] [Related]
25. Albumin-to-globulin ratio (AGR) as a potential marker of predicting lupus nephritis in Chinese patients with systemic lupus erythematosus.
Liu XR; Qi YY; Zhao YF; Cui Y; Wang XY; Zhao ZZ
Lupus; 2021 Mar; 30(3):412-420. PubMed ID: 33407045
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and renal survival of patients with lupus nephritis with glomerular immunoglobulin G
Jiang X; Lan L; Zhou Q; Wang H; Wang H; Chen J; Han F
Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35710146
[TBL] [Abstract][Full Text] [Related]
27. Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings.
Abd-Elkareem MI; Al Tamimy HM; Khamis OA; Abdellatif SS; Hussein MR
Clin Exp Nephrol; 2010 Dec; 14(6):548-57. PubMed ID: 20714774
[TBL] [Abstract][Full Text] [Related]
28. Serum Levels of Transforming Growth Factor Beta -1 (TGF-β1) as An Early No Invasive Marker for Diagnosis of Lupus Nephritis in Systemic Lupus Erythematosus Patients.
Rashad NM; El-Shabrawy RM; Said D; El-Shabrawy SM; Emad G
Egypt J Immunol; 2019 Jan; 26(1):31-42. PubMed ID: 31332994
[TBL] [Abstract][Full Text] [Related]
29. Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus.
Faustini F; Idborg H; Fuzzi E; Larsson A; Lie WR; Pötzsch S; Okitsu SL; Svenungsson E; Gunnarsson I
Lupus; 2023 Feb; 32(2):252-262. PubMed ID: 36508734
[TBL] [Abstract][Full Text] [Related]
30. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
[TBL] [Abstract][Full Text] [Related]
31. Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.
Abdulahad DA; Westra J; Bijzet J; Dolff S; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
Arthritis Res Ther; 2012 Aug; 14(4):R184. PubMed ID: 22892043
[TBL] [Abstract][Full Text] [Related]
32. Clinical and functional consequences of anti-properdin autoantibodies in patients with lupus nephritis.
Radanova M; Mihaylova G; Ivanova D; Daugan M; Lazarov V; Roumenina L; Vasilev V
Clin Exp Immunol; 2020 Aug; 201(2):135-144. PubMed ID: 32306375
[TBL] [Abstract][Full Text] [Related]
33. Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus.
Ishizaki J; Saito K; Nawata M; Mizuno Y; Tokunaga M; Sawamukai N; Tamura M; Hirata S; Yamaoka K; Hasegawa H; Tanaka Y
Rheumatology (Oxford); 2015 Mar; 54(3):405-12. PubMed ID: 25183834
[TBL] [Abstract][Full Text] [Related]
34. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
Front Immunol; 2022; 13():885307. PubMed ID: 35720325
[TBL] [Abstract][Full Text] [Related]
35. Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis.
Zickert A; Palmblad K; Sundelin B; Chavan S; Tracey KJ; Bruchfeld A; Gunnarsson I
Arthritis Res Ther; 2012 Feb; 14(1):R36. PubMed ID: 22348591
[TBL] [Abstract][Full Text] [Related]
36. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
[TBL] [Abstract][Full Text] [Related]
37. Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis.
Häyry A; Faustini F; Zickert A; Larsson A; Niewold TB; Svenungsson E; Oke V; Gunnarsson I
Lupus Sci Med; 2022 Sep; 9(1):. PubMed ID: 36104119
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis.
Gonzalo E; Toldos O; Martínez-Vidal MP; Ordoñez MC; Santiago B; Fernández-Nebro A; Loza E; García I; León M; Pablos JL; Galindo M
Arthritis Res Ther; 2012 May; 14(3):R126. PubMed ID: 22640796
[TBL] [Abstract][Full Text] [Related]
39. Plasma immunoglobulin binding protein 1 as a predictor of development of lupus nephritis.
Kwon OC; Lee EJ; Oh JS; Hong S; Lee CK; Yoo B; Park MC; Kim YG
Lupus; 2020 May; 29(6):547-553. PubMed ID: 32183589
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
